News About: Pharm. Industry


Daewoong to enter the major psychotic markets

Daewoong (CEO: Yoon Jae-seung) announced to launch Spendalin (Risperidone) 2mg tablet, a drug for schizophrenia in the middle of Aug. aiming at an active entry of major psychotic drug markets. Spendalin (Risperidon...

Korea Credit Guarantee Fund policy found unchanged.

So far the drug wholesalers worried with a rumor that the loan of the credit guarantee fund, one of very important financial sources for the pharmaceutical wholesalers in Korea, might be cut down without regard to the...

Understanding of markets and social structures key success factors in China.

The key business success in China lies in the adequate understanding of the decision making structures in the Chinese society and the way of thoughts of Chinese people including well awareness of the economic level an...

Medipost Inc. to merge a bio tech company, Curonix

Medipost Inc. announced on Aug. 23 that the company merged Curonix, a company specialized in the development and distribution of cancer drugs, cancer diagnostic reagents and other bio new drugs. Medipost is special...

GSK's clinical studies in Korea on the rise.

The foreign multinational drug corporations showed ever growing investment for the local clinical study projects in Korea, and GSK emerged as one of the most active companies to induce global clinical study programs i...

Profit structures of list drug companies remarkably improved.

The listed drug companies having a fiscal year ended at March 31, reported the business performance of the 1st quarter of FY2005, showing a substantial improvement of their profits largely due to the aggressive market...

Anti-obesity and impotence drugs most abused.

Prof. Kwon Kyeong-hee of the College of Pharmacy, Seoul National University reported in her recent study on the drug abuse in Korea that the drugs for diet and male impotence found most abused by purchasing them throu...

Green Cross to construct flu vaccine facility by 2007.

Green Cross announced on Aug. 22 that the company planned to construct a large plant for the flu vaccine production in Hwasoon, Jeonnam province by 2007. The total 200 billion won including 90 BW of R&D and 16 BW o...

DI center to launch in March next year.

The MOHW fixed the basic project to visualize the establishment of the Drug Information (DI) Center to run in March next year after a full discussion with the DI Center Foundation and Administration Planning Squad and...

Hanmi to register patent for a modified G-CSF in Europe.

Hanmi announced on Aug. 19 that the patent for the production and process of "a modified stimulant (G-CSF) of human granulocyte colony", a protein for the treatment of leukocytopenia accompanied by the chemotherapy wa...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.